WRN-IN-23
WRN-IN-23 is a Werner Syndrome helicase enzyme (WRN) inhibitor. WRN-IN-23 inhibits the ATP-dependent helicase domain activity of WRN. WRN-IN-23 can be used for the research of cancers characterized by microsatellite instability (MSI) and/or defective DNA mismatch repair system (dMMR).
For research use only. We do not sell to patients.
- CAS No.: 2923008-65-3
- Formula: C16H20N2O4S
- Molecular Weight:336.41
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
All DNA/RNA Synthesis Isoforms
More
Biological Activity
|
Helicase |
WRN-IN-23 shows a pIC50 of 6-7 for WRN[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
Chemical Information
-
CAS No. 2923008-65-3
-
Molecular Weight 336.41
-
Formula C16H20N2O4S
-
SMILES
O=C1NC(C2CCCCC2)=CC=C1C(N[C@H]3C=CS(=O)(C3)=O)=O
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Purity & Documentation
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)